Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Oku

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Modern Rheumatology|August 23, 2014
Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complicationsYuko Matsuki, Tatsuya Atsumi, Koushi Yamaguchi, et al.
Rheumatology (Oxford, England)|September 18, 2020
Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort studyYusuke Ogata, Yuichiro Fujieda, Masanari Sugawara, et al.
Clinical and Experimental Rheumatology|May 18, 2021
The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertensionKeita Ninagawa, Masaru Kato, Hiroshi Ohira, et al.
Rheumatology (Oxford, England)|April 17, 2016
Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndromeKenji Oku, Olga Amengual, Ryo Hisada, et al.
Rheumatology (Oxford, England)|December 7, 2018
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosusRyo Hisada, Masaru Kato, Naoki Ohnishi, et al.
Autoimmunity Reviews|August 4, 2016
Complement and thrombosis in the antiphospholipid syndromeKenji Oku, Hiroyuki Nakamura, Michihiro Kono, et al.
Rheumatology (Oxford, England)|January 12, 2020
Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositisKohei Karino, Michihiro Kono, Michihito Kono, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 28, 2015
[The function and the significance of full-automated tests for detecting antiphospholipid antibodies]Kenji Oku, Olga Amengual, Ryo Hisada, et al.
Thrombosis Research|August 24, 2016
Significance of fully automated tests for the diagnosis of antiphospholipid syndromeKenji Oku, Olga Amengual, Masaru Kato, et al.
Arthritis Research & Therapy|April 19, 2018
Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysisKazumasa Ohmura, Masaru Kato, Toshiyuki Watanabe, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Modern Rheumatology|August 23, 2014
Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complicationsYuko Matsuki, Tatsuya Atsumi, Koushi Yamaguchi, et al.
Rheumatology (Oxford, England)|September 18, 2020
Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort studyYusuke Ogata, Yuichiro Fujieda, Masanari Sugawara, et al.
Clinical and Experimental Rheumatology|May 18, 2021
The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertensionKeita Ninagawa, Masaru Kato, Hiroshi Ohira, et al.
Rheumatology (Oxford, England)|April 17, 2016
Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndromeKenji Oku, Olga Amengual, Ryo Hisada, et al.
Rheumatology (Oxford, England)|December 7, 2018
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosusRyo Hisada, Masaru Kato, Naoki Ohnishi, et al.
Autoimmunity Reviews|August 4, 2016
Complement and thrombosis in the antiphospholipid syndromeKenji Oku, Hiroyuki Nakamura, Michihiro Kono, et al.
Rheumatology (Oxford, England)|January 12, 2020
Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositisKohei Karino, Michihiro Kono, Michihito Kono, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 28, 2015
[The function and the significance of full-automated tests for detecting antiphospholipid antibodies]Kenji Oku, Olga Amengual, Ryo Hisada, et al.
Thrombosis Research|August 24, 2016
Significance of fully automated tests for the diagnosis of antiphospholipid syndromeKenji Oku, Olga Amengual, Masaru Kato, et al.
Arthritis Research & Therapy|April 19, 2018
Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysisKazumasa Ohmura, Masaru Kato, Toshiyuki Watanabe, et al.
Pageof 9